AstraZeneca

AstraZeneca settles another Nexium patent litigation for US sales

07 Jan 2010

AstraZeneca to acquire Novexel for $350 million, expand alliance with Forest Labs

24 Dec 2009

AstraZeneca says its new anti-clotting drug better than Plavix

31 Aug 2009

AstraZeneca, Merck & Co to in phase 1 cancer drug research

01 Jun 2009

Jubilant signs research deal with Anglo-Swedish firm AstraZeneca

06 May 2009

Infosys wins multi-million dollar AstraZeneca deal

15 Dec 2008

AstraZeneca, Abraxis rethink cancer drug deal

26 Nov 2008

AstraZeneca agrees to cut drug prices in UK, stock plummets

20 Nov 2008

US court ruling helps AstraZeneca stave off Teva, Sandoz from 4$-billion Seroquel

03 Jul 2008

A US court has upheld  Anglo-Swedish pharmaceutical group AstraZeneca's patent rights to the over $4 billion a year schizophrenia and bipolar blockbuster Seroquel

Ranbaxy settles litigation with AstraZeneca; to sell Nexium in US

15 Apr 2008

With the settlemrent of the patent litigation with AstraZeneca, Ranbaxy's US subsidiary  will commence exclusive marketing of a generic version of ulcer drug Nexium in 2014 in the US

AstraZeneca forms clinical research venture with private equity firms

18 Feb 2008

AstraZeneca acquires paediatric asthma development programmes from Verus Pharmaceuticals

By | 25 Sep 2007

AstraZeneca to acquire US biotech firm MedImmune for $15.6 billion

28 Apr 2007

Global collaboration to develop new anti-obesity compounds

By Our Corporate Bureau | 02 Feb 2007

Nicholas Piramal India Limited signs 10-year manufacturing and supply agreement

By Mumbai: | 24 Nov 2005

AstraZeneca sues Ranbaxy on Nexium patent

By Our Corporate Bureau | 22 Nov 2005

AstraZeneca to drop Viozan

By Our Corporate Bureau | 29 Jun 2001

AstraZeneca launches $ 100 million facility in China

By Our Corporate Bureau | 30 Apr 2001

AstraZeneca to acquire development rights from Cyclacel

By Our Corporate Bureau | 17 Apr 2001

AstraZeneca sells off speciality chemicals

By Our Corporate Bureau | 13 May 1999

Cheminor unfazed by AstraZeneca patent infringement suit

By Ananth Iyer | 13 May 1999